June 3, 2019
CMIC HOLDINGS Co., Ltd.

As disclosed in “Announcement on transfer of a Subsidiary (Sub-subsidiary)-Assignment of Nishine Plant from Astellas Pharma Tech Co., Ltd. by CMIC CMO-” on December 21, 2018, CMIC CMO Co., Ltd., a consolidated subsidiary of CMIC HOLDINGS Co., Ltd.. operating a CDMO (Contract Development and Manufacturing Organization) business has completed the stock transfer procedure with Astellas Pharma Tech Co., Ltd. as of June 1, 2019, and CMIC HOLDINGS Co., Ltd.. hereby announces that CMIC CMO Nishine Co., Ltd. (A successor company of Nishine Plant business) has become a subsidiary (Sub-subsidiary) of CMIC HOLDINGS Co., Ltd..
This change should have an immaterial impact on financial statements (the fiscal year ending September 30, 2019).

Overview of Transferred Subsidiary (Sub-subsidiary)

(1)NameCMIC CMO NISHINE Co., Ltd.
(2)LocationObuke 2-154-13, Hachimantai-city, Iwate
(3)RepresentativeRepresentative Director, Motoyoshi Katano
(4)OperationsManufacturing of pharmaceutical products
(5)Capital¥100 million
(6)Date of establishmentJanuary 17, 2019
(7)Major shareholders and shareholding ratioCMIC CMO Co., Ltd. (Shareholding ratio:100%)

 

PDF Completion of Transfer of a Subsidiary (Sub-subsidiary) (Update on Previously Disclosed Transaction) -Completion of assignment of Nishine Plant from Astellas Pharma Tech by CMIC CMO-